"目录号: HY-14622 ee.: 99.20%
Necrostatin 2 是一种有效的程序性坏死 (necroptosis) 抑制剂。作用于TNF-α处理的FADD缺陷型Jurkat T细胞，抑制程序性坏死，EC50为 0.05 μM。
相关产品
Lenalidomide-Pomalidomide-TIC10-Necrostatin 2 racemate-Cot inhibitor-2-C 87-Mesaconitine-Sinensetin-Cot inhibitor-1-DCVC-Taurochenodeoxycholic acid-Bioymifi-Forsythoside B-Homoplantaginin-Hypaconitine-
生物活性
Description
Necrostatin 2 is a potentnecroptosisinhibitor.EC50for inhibition of necroptosis in FADD-deficient Jurkat T cells treated withTNF-αis 0.05 μM.
IC50& Target
Necroptosis[1]
In Vitro
Evaluation of necroptosis inhibitory activity is performed using a FADD-deficient variant of human Jurkat T cells treated with TNF-α. Utilizing these conditions the cells efficiently undergo necroptosis, which is completely and selectively inhibited by Necrostatin 2 (EC50=50 nM). Necrostatin 2 shows activity in a broad range of necroptosis cellular systems[1]. Necrostatin 2 at 30 μM completely protects L929 cells from TNF-α-induced necroptosis. In addition to TNF-α, the pan-caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone (zVAD.fmk) has also been found to induce necrosis in L929 cells, which is efficiently inhibited by Necrostatin 2[2]. EC50for inhibition of necroptosis in FADD-deficient Jurkat T cells treated with TNF-α is 0.05 μM[3].
References
